Haematological cancer: The rule of three in AML induction--is cladribine the answer?
Frederick R
FR
Appelbaum
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017338:Cladribine / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction
D000970:Antineoplastic Agents; D017338:Cladribine